Drug Pricing

Blog

What We’re Watching – September 18

Tim Anaya – Making the Entire Health Care System More Affordable In the final episode in PRI’s “Escape the Drug Pricing Maze” series, the Professor and Pete visit the City of Free Enterprise and learn that reforms to make the entire health care system more affordable are critical to making ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary

Trump’s Drug Pricing Order Is A Costly Mistake

On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Commentary

California should not get into the drug manufacturing business

In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Blog

California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients

The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
Blog

California’s Worst Bills of the Legislative Session

The final gavel fell last week on the 2020 legislative session.  Cut short by seven weeks due to the coronavirus, lawmakers were forced to take a backseat to Gov. Newsom, who made use of his wide-ranging emergency powers to lock down businesses to stop the spread of the virus and ...
Commentary

A Look At The Democrats’ Not-So-Moderate Healthcare Platform

At their virtual convention this week, Democrats went to great lengths to communicate that they were united in their quest to defeat President Trump. Health care would appear to be the exception to that spirit of unity. More than 700 delegates to the Democratic National Convention said beforehand they’d oppose ...
Blog

What We’re Watching – August 28

Ben Smithwick – Helping Citizens Understand a World without Fossil Fuels Ronald Stein, co-author of the new book Just GREEN Electricity – Helping Citizens Understand a World without Fossil Fuels, discusses the dangers of overreliance on renewable energy. Click here to watch the video Tim Anaya – Making Biosimilars and ...
Commentary

Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic

The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
Blog

What We’re Watching – August 14

Tim Anaya – Reforming Patient Costs at the Pharmacy In the latest video in the Pacific Research Institute “Escape the Drug Pricing Maze” series, the Professor and Pete must collect 3 keys to finally escape the drug pricing maze. The first key involves reforms to increase drug affordability for patients ...
Blog

What We’re Watching – September 18

Tim Anaya – Making the Entire Health Care System More Affordable In the final episode in PRI’s “Escape the Drug Pricing Maze” series, the Professor and Pete visit the City of Free Enterprise and learn that reforms to make the entire health care system more affordable are critical to making ...
Commentary

Price Controls Are Disastrous For Rents And Will Be For Drugs

President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary

Trump’s Drug Pricing Order Is A Costly Mistake

On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Commentary

California should not get into the drug manufacturing business

In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Blog

California Entering Pharmaceutical Business Won’t Lower Drug Prices for Patients

The state of California, which can’t keep the lights on thanks to political interference in energy generation, nor build enough homes because government has poisoned the housing market, is going into the pharmaceutical manufacturing business. But there’s nothing to worry about. If it struggles, taxpayers will be there to bail ...
Blog

California’s Worst Bills of the Legislative Session

The final gavel fell last week on the 2020 legislative session.  Cut short by seven weeks due to the coronavirus, lawmakers were forced to take a backseat to Gov. Newsom, who made use of his wide-ranging emergency powers to lock down businesses to stop the spread of the virus and ...
Commentary

A Look At The Democrats’ Not-So-Moderate Healthcare Platform

At their virtual convention this week, Democrats went to great lengths to communicate that they were united in their quest to defeat President Trump. Health care would appear to be the exception to that spirit of unity. More than 700 delegates to the Democratic National Convention said beforehand they’d oppose ...
Blog

What We’re Watching – August 28

Ben Smithwick – Helping Citizens Understand a World without Fossil Fuels Ronald Stein, co-author of the new book Just GREEN Electricity – Helping Citizens Understand a World without Fossil Fuels, discusses the dangers of overreliance on renewable energy. Click here to watch the video Tim Anaya – Making Biosimilars and ...
Commentary

Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic

The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
Blog

What We’re Watching – August 14

Tim Anaya – Reforming Patient Costs at the Pharmacy In the latest video in the Pacific Research Institute “Escape the Drug Pricing Maze” series, the Professor and Pete must collect 3 keys to finally escape the drug pricing maze. The first key involves reforms to increase drug affordability for patients ...
Scroll to Top